SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-048392
Filing Date
2023-09-15
Accepted
2023-09-15 16:30:09
Documents
12
Period of Report
2023-09-13
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K apvo-20230913.htm   iXBRL 8-K 45755
  Complete submission text file 0000950170-23-048392.txt   166157

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apvo-20230913_pre.xml EX-101.PRE 10302
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apvo-20230913.xsd EX-101.SCH 2487
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apvo-20230913_lab.xml EX-101.LAB 14028
6 EXTRACTED XBRL INSTANCE DOCUMENT apvo-20230913_htm.xml XML 4925
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 231259133
SIC: 2834 Pharmaceutical Preparations